Morphological and Molecular Characterization of KRAS G12C-Mutated Lung Adenocarcinomas.

Pirlog, Radu; Piton, Nicolas; Lamy, Aude; Guisier, Florian; Berindan-Neagoe, Ioana; Sabourin, Jean-Christophe; Marguet, Florent

Pirlog, Radu; Piton, Nicolas; Lamy, Aude; Guisier, Florian; Berindan-Neagoe, Ioana; Sabourin, Jean-Christophe; Marguet, Florent.

Afiliación

Pirlog R; Pathology Department and INSERM U1245, Rouen University Hospital, Normandy University, 76000 Rouen, France.
Piton N; Research Center for Functional Genomics Biomedicine and Translational Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
Lamy A; Pathology Department and INSERM U1245, Rouen University Hospital, Normandy University, 76000 Rouen, France.
Guisier F; Pathology Department and INSERM U1245, Rouen University Hospital, Normandy University, 76000 Rouen, France.
Berindan-Neagoe I; Department of Pulmonology, Thoracic Oncology and Respiratory Intensive Care, Rouen University Hospital, 76000 Rouen, France.
Sabourin JC; Research Center for Functional Genomics Biomedicine and Translational Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
Marguet F; Pathology Department and INSERM U1245, Rouen University Hospital, Normandy University, 76000 Rouen, France.

Cancers (Basel) ; 14(4)2022 Feb 17.

Article en En | MEDLINE | ID: mdl-35205778

Palabras clave

KRAS; KRAS G12C; STK11; lung adenocarcinoma; targeted therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google